UCBJF:OTCMKTS
UCB
239,14 USD
arrow_downward
-0,46%(-1,10) 1 d.
16. 10., 16:00:00 GMT-4 · USD
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre UCBJF…
Otvoriť
239,14 USD
Vysoká
239,14 USD
Nízka
239,14 USD
Trh. kap.
39,39 mld.
Priem. obj.
127,00
Objem
107,00
Max. za 52 týž.
345,39 USD
Min. za 52 týž.
219,60 USD
Beta
0,58
Akcie v obehu
194,51 mil.
Počet zamestnancov
9 tis.
Otvoriť
239,14 USD
Vysoká
239,14 USD
Nízka
239,14 USD
Trh. kap.
39,39 mld.
Priem. obj.
127,00
Objem
107,00
Max. za 52 týž.
345,39 USD
Min. za 52 týž.
219,60 USD
Beta
0,58
Akcie v obehu
194,51 mil.
Počet zamestnancov
9 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
ad-hoc-news.de
·
pred 10 hodinami
UCB launches Wear It Out: what it means for UCB stock
Profil
UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system disorders, inflammatory disorders, and oncology.
Every three years, the company presents the UCB Award under the patronage of the Queen Elisabeth Medical Foundation to promote neuroscience research. The winner of this award is selected by an independent scientific committee. Wikipedia
Informácie o subjekte UCB
Generálny riaditeľJean-Christophe Tellier
Zamestnanci9 tis.
Dátum založenia18. 1. 1928
Hlavné sídlo-
Odvetvie-
Webucb.com